Professor Siobhan Glavey is the Academic Head of the Department of Pathology at the Royal College of Surgeons in Ireland (RCSI). She is a haematologist and a physician scientist focused on multiple myeloma and leads a research group at RCSI focused on precision medicine and the application of genomics in this disease. She is also the Academic Lead for the Molecular Pathology Laboratory at RCSI, a nationally accredited laboratory for cancer genomics that provides national minimal residual disease (MRD) testing for myeloma patients in Ireland.

She received her medical degree from NUI, Galway and completed her internal medical training at Galway University Hospital and at the Mayo Clinic College of Medicine, Rochester MN. Her haematology clinical training took place in Ireland through the Royal College of Physicians of Ireland and she completed her PhD at the Dana Farber Cancer Institute, Harvard Medical School, Boston, USA. She is a fellow of the Royal College of Pathologists, London and a fellow of the Royal College of Physicians in Ireland.

Her research focuses on understanding the genomic mechanisms driving high-risk myeloma disease states and the application of state-of-the-art precision medicine technologies to patient treatment selection, prognosis prediction and outcome assessments. Her research has involved the use of AI to assist pathological and genomic diagnostics in myeloma and other cancers. She is a founding member of the Irish Multiple Myeloma Society and has co-authored over 100 publications and book chapters. She has received funding support from the American Society of Haematology, Breakthrough Cancer Research, Irish Cancer Society, Health Research Board and others. She continues to collaborate with a number of leading multiple myeloma research groups throughout the world and is committed to bettering the care of multiple myeloma patients in Ireland.